Disposition of docosahexaenoic acid-paclitaxel, a novel taxane, in blood: in vitro and clinical pharmacokinetic studies.

Disposition of docosahexaenoic acid-paclitaxel, a novel taxane, in blood: in vitro and clinical pharmacokinetic studies.

Item
http://www.wikidata.org/entity/Q33185773
Tumor-targeting drug delivery of new-generation taxoids.Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer.Update on taxane development: new analogs and new formulationsA dicarboxylic fatty acid derivative of paclitaxel for albumin-assisted drug delivery.Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters.Fluorine-Containing Taxoid Anticancer Agents and Their Tumor-Targeted Drug Delivery.Exploration of fluorine chemistry at the multidisciplinary interface of chemistry and biology.Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity.Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer.Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice.
P2860

Disposition of docosahexaenoic acid-paclitaxel, a novel taxane, in blood: in vitro and clinical pharmacokinetic studies.

Item
http://www.wikidata.org/entity/Q33185773
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Disposition of docosahexaenoic ...... nical pharmacokinetic studies.
@ast
Disposition of docosahexaenoic ...... nical pharmacokinetic studies.
@en
type
label
Disposition of docosahexaenoic ...... nical pharmacokinetic studies.
@ast
Disposition of docosahexaenoic ...... nical pharmacokinetic studies.
@en
prefLabel
Disposition of docosahexaenoic ...... nical pharmacokinetic studies.
@ast
Disposition of docosahexaenoic ...... nical pharmacokinetic studies.
@en
P1433
P1476
P2093
P304
P31
P407
P433
P478
P50
P577
P698
P1433
P1476
Disposition of docosahexaenoic ...... inical pharmacokinetic studies
@en
P2093
P304
P31
P407
P433
P478
P50
P577
P698